(Q41524622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kelvin Kai-Wang To

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yuen Kwok-yung

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

Candy C Y Lau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

9

Wai-Lan Wu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

7

Chuan-Gen Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

Jian-Piao Cai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

8

Akhee S Jahan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Anna J X Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Andy S F Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Can Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Lanjuan Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alan Ka-Lun Tsang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kwok-Hung Chan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

24 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

777-786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25616843%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00705-014-2314-x

28 February 2020

exact match

0 references

cites work

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Analytical sensitivity of seven point-of-care influenza virus detection tests and two molecular tests for detection of avian origin H7N9 and swine origin H3N2 variant influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Two years after pandemic influenza A/2009/H1N1: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Clinical findings in 111 cases of influenza A (H7N9) virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Human infection with a novel avian-origin influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Immunobiology of influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Limited airborne transmission of H7N9 influenza A virus between ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

High incidence of severe influenza among individuals over 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

H7N9 influenza viruses are transmissible in ferrets by respiratory droplet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X

Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-014-2314-X